Skip to content
Recall Observatory FDA recall evidence

Drug product

Nature-Throid, Thyroid USP [liothyronine (T3) 20.25 mcg and levothyroxine (T4) 85.5 mcg], 2.25 Grain (146.25 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3309-4; b) 60-count bottles, NDC 64727-3309-5; c) 90-count bottles, NDC 64727-3309-6; d) 100-count bottles, NDC 64727-3309-1; and e) 1,000-count bottles, NDC 64727-3309-2; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034.

D-1603-2020

August 25, 2020

Class II

Product summary

Firm
RLC Labs Inc.
Event
Event 86343
Status
Terminated
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-1603-2020

Official wording

Reason: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Code information: All lots with expiry between 10/2020-07/2023

Distribution pattern: Nationwide in the United States

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations
  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    subpotent